We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

News   Jan 17, 2018 | Original story from The Salk Institute

 
The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

Salk's CSO Martin Hetzer, Cancer Center Director Reuben Shaw and Director of Business Development Tari Suprapto pictured with Indivumed's Founder and CEO Hartmut Juhl and Managing Director Andrew Deubler. Credit: Salk Institute

 
 
 

RELATED ARTICLES

Brain Cancer Potentially Resists Immunotherapies by Trapping T Cells in Bone Marrow

News

Certain brain cancers are associated with low numbers of immune system T-cells circulating in the peripheral blood. Low T-cell numbers can be a side-effect of cancer treatment. But it now appears that there is more to the story of these missing T-cells.

READ MORE

Retinoic Acid may Improve Immune Response Against Melanoma

News

Scientists have found a promising strategy to remove one of melanoma’s most powerful defenses, leading to more immune system activity directed at melanoma.

READ MORE

PCR Assay Helps ID Sarcoma Mutations

News

Sarcomas are rare tumors that are often misdiagnosed. A report in the Journal of Molecular Diagnostics describes a new assay, anchored multiplex PCR (AMP)-based targeted next-generation-sequencing (NGS), that is better able to identify genetic diagnostic markers of the cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE